Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) EBT (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed EBT for 9 consecutive years, with $50.3 million as the latest value for Q4 2025.

  • Quarterly EBT rose 37.35% to $50.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.7 million through Dec 2025, up 12.39% year-over-year, with the annual reading at $65.7 million for FY2025, 12.39% up from the prior year.
  • EBT hit $50.3 million in Q4 2025 for Inspire Medical Systems, up from $13.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $50.3 million in Q4 2025 to a low of -$16.6 million in Q3 2022.
  • Historically, EBT has averaged $900300.0 across 5 years, with a median of -$5.3 million in 2021.
  • Biggest five-year swings in EBT: skyrocketed 365.34% in 2023 and later plummeted 121.5% in 2025.
  • Year by year, EBT stood at -$2.4 million in 2021, then skyrocketed by 238.13% to $3.3 million in 2022, then soared by 365.34% to $15.2 million in 2023, then skyrocketed by 140.39% to $36.6 million in 2024, then surged by 37.35% to $50.3 million in 2025.
  • Business Quant data shows EBT for INSP at $50.3 million in Q4 2025, $13.6 million in Q3 2025, and -$2.3 million in Q2 2025.